Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Jan;41(1):96-101.
doi: 10.1038/ijo.2016.175. Epub 2015 Oct 4.

Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis

Affiliations
Meta-Analysis

Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis

W S Leslie et al. Int J Obes (Lond). 2017 Jan.

Erratum in

Abstract

Aim: To provide a systematic review, of published data, to compare weight losses following very low calorie (<800 kcal per day VLCD) or low-energy liquid-formula (>800 kcal per day LELD) diets, in people with and without type 2 diabetes mellitus (T2DM).

Methods: Systematic electronic searches of Medline (1946-2015) and Embase (1947-2015) to identify published studies using formula total diet replacement diets (VLCD/LELD). Random effects meta-analysis using weighted mean difference (WMD) in body weight between groups (with and without diabetes) as the summary estimate.

Results: Final weight loss, in the five included studies, weighted for study sizes, (n=569, mean BMI=35.5-42.6 kg/m2), was not significantly different between participants with and without T2DM: -1.2 kg; 95% CI: -4.1 to 1.6 kg). Rates of weight loss were also similar in the two groups -0.6 kg per week (T2DM) and 0.5 kg per week (no diabetes), and for VLCD (<800 kcal per day) and LELD (>800 kcal per day).

Conclusions: Weight losses with liquid-formula diets are very similar for VLCD and LELD and for obese subjects with or without T2DM. They can potentially achieve new weight loss/ maintenance targets of >15-20% for people with severe and medically complicated obesity.

PubMed Disclaimer

Conflict of interest statement

WSL, MEJL and RT are currently engaged on the Diabetes Remission Clinical Trial (DiRECT) funded by Diabetes UK with additional support in kind from Cambridge Weight Plan. MEJL and RT have received support related to the use of formula diet products from Cambridge Weight Plan and from Nestle.

Figures

Figure 1
Figure 1
Flowchart of progress of papers through the review.
Figure 2
Figure 2
Meta-analysis (WMD) of studies comparing weight losses in those with type 2 diabetes and non-diabetic subjects.

References

    1. Walker A. The Cost of Doing Nothing: The Economics of Obesity in Scotland. Robertson Centre for Biostatistics, University of Glasgow: Glasgow, 2003.
    1. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961–969. - PubMed
    1. UKPDS UK. Prospective Diabetes Study (UKPDS) VIII. Study, design, progress and performance. Diabetology 1991; 34: 877–890. - PubMed
    1. Lean ME, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 1990; 7: 228–233. - PubMed
    1. Scottish Health Survey. Available from: http://www.scotland.gov.uk/Publications/2009/09/28102003/0, 2008.

MeSH terms